Related Experiment Video
Updated: May 10, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
What percolation theory can tell us about COPD
1St John's University, New York, NY, United States. jocantor1@gmail.com
Medical Hypotheses
|June 14, 2013
Summary
Urinary desmosine and isodesmosine (DID) patterns, not just levels, may indicate chronic obstructive pulmonary disease (COPD) progression. The ratio of free to bound DID could measure emphysematous changes in the lungs.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Network Physiology
Background:
- Lung elastic fiber damage is central to chronic obstructive pulmonary disease (COPD) pathogenesis.
- Desmosine and isodesmosine (DID) are unique elastic fiber crosslinks proposed as COPD biomarkers.
- Current DID measurements in COPD patients show high variability, limiting prognostic value.
Purpose of the Study:
- To investigate if specific patterns of DID release reflect lung morphological changes in COPD.
- To establish urinary free and peptide-bound DID as indicators of damaged and intact elastic fibers, respectively.
- To determine if the ratio of free to bound DID correlates with emphysematous changes in COPD.
Main Methods:
- Utilized percolation theory to model the lung's elastic fiber network.
- Analyzed urinary levels of free and peptide-bound DID.
- Correlated DID release patterns with emphysematous changes in COPD patients.
Main Results:
- Percolation theory models suggest urinary free and bound DID reflect damaged and intact elastic fibers.
- The ratio of free to bound DID shows potential as a measure of emphysematous changes.
- Specific DID release patterns may offer improved prognostic value over absolute quantities in COPD.
Conclusions:
- Urinary free and bound DID levels, and their ratio, can serve as molecular indicators of elastic fiber integrity and emphysema in COPD.
- This approach may overcome the limitations of current DID measurements, offering better prognostic insights.
- Further research is warranted to validate DID patterns as reliable biomarkers for COPD progression and severity.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History